Coologics' Revolutionary Temperature-Based Approach to Vaginal Infections

In women's health, innovation is not just a buzzword but a necessity. Coologics, a forward-thinking femtech company, is at the forefront of this innovation with their platform technology, Vlisse, a patented, drug-free treatment for vaginal infections, including yeast infections and bacterial vaginosis. 

In women's health, vaginal issues are paramount, with 30% of gynecological visits due to vaginitis, mainly from yeast infections and bacterial vaginosis (BV). The annual US market for yeast and BV treatments is collectively valued at $6 billion. Alarmingly, 75% of women will experience a yeast infection, and 34% suffer from multiple infections every year. Despite various products, 80% of women are dissatisfied with leading over-the-counter solutions, and the rise of antibiotic resistance intensifies the need for novel solutions, especially for BV. Current practices of full-course antibiotics, which indiscriminately target all bacteria throughout the body, are often ineffective and perilous, posing risks of harmful imbalances and recurrent infections. 

Read more.